Search - tctmd.com

Displaying 1 - 20 of 3972

Sort: Relevancy | Date

Disparities Widen Across Regions as Global Hypertension Burden Grows

News Daily News

Disparities Widen Across Regions as Global Hypertension Burden Grows

April 03, 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

News Conference News ACC 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

Yael L. Maxwell

April 03, 2026

Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

News Conference News ACC 2026

Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

April 02, 2026

TCTMD’s Top 10 Most Popular Stories for March 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

April 01, 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

News Conference News ACC 2026

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

March 29, 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

News Conference News ACC 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

March 28, 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

March 28, 2026

Evolocumab in Patients without Known Atherosclerosis and with Diabetes: Secondary Analysis from VESALIUS-CV

Presentation ACC 2026

Evolocumab in Patients without Known Atherosclerosis and with Diabetes: Secondary Analysis from VESALIUS-CV

Presenter: Nicholas Marston

March 28, 2026

March 2026 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

March 26, 2026

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

March 25, 2026

Several Factors Linked to Subsequent Events After TIA, Minor Stroke

News Daily News

Several Factors Linked to Subsequent Events After TIA, Minor Stroke

March 23, 2026

Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race

News Daily News

Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race

March 23, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1

News Daily News

Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1

March 19, 2026

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

News Daily News

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Yael L. Maxwell

March 19, 2026

LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF

News Conference News

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF

March 18, 2026

No Major Progress on Making CV Care More Affordable: JACC Stats

News Daily News

No Major Progress on Making CV Care More Affordable: JACC Stats

March 18, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.